NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.
Aphria Inc. (NYSE: APHA) Class Period: July 17, 2018 - December 4, 2018 Lead Plaintiff Deadline: February 5, 2019 Join the action: https://www.zlk.com/pslra-1/aphria-inc-loss-form?wire=3
The lawsuit alleges: Aphria Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) the Latin American assets acquired by the Company lacked adequate licenses to operate and were overvalued; (2) the acquisition of the Latin American assets would enrich the Company’s CEO and other insiders at the expense of shareholders; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
To learn more about the Aphria Inc. class action contact jlevi@levikorsinsky.com .
Teladoc Health, Inc. (NYSE: TDOC) Class Period: March 3, 2016 - December 5, 2018 Lead Plaintiff Deadline: February 11, 2019 Join the action: https://www.zlk.com/pslra-1/teladoc-health-in...orm?wire=3
The lawsuit alleges: Teladoc Health, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Executive Vice President and Chief Operating Officer Mark Hirschhorn was engaged in an inappropriate sexual relationship with a subordinate; (ii) Hirschhorn and this subordinate engaged in insider trading to provide themselves with undue benefits; (iii) Hirschhorn caused the subordinate to receive promotions for which she was unqualified, thereby negatively impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading policies were inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
To learn more about the Teladoc Health, Inc. class action contact jlevi@levikorsinsky.com .
Activision Blizzard, Inc. (NASDAQ: ATVI) Class Period: August 2, 2018 - January 10, 2019 Lead Plaintiff Deadline: March 19, 2019 Join the action: https://www.zlk.com/pslra-1/activision-blizza...orm?wire=3
The lawsuit alleges: Activision Blizzard, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) the termination of Activision Blizzard and Bungie's partnership, giving Bungie full publishing rights and responsibilities for the Destiny franchise, was imminent; (ii) the termination of the two companies' relationship would foreseeably have a significant negative impact on Activision Blizzard's revenues; and (iii) as a result, Activision Blizzard's public statements were materially false and misleading at all relevant times.
To learn more about the Activision Blizzard, Inc. class action contact jlevi@levikorsinsky.com .
Astec Industries, Inc. (NASDAQ: ASTE) Class Period: July 26, 2016 - October 22, 2018 Lead Plaintiff Deadline: April 2, 2019 Join the action: https://www.zlk.com/pslra-1/astec-industries-...orm?wire=3
The complaint alleges that throughout the Class Period, defendants made false and misleading statements and/or failed to disclose adverse information regarding Astec’s business, operations and prospects, including that its wood pellet plants suffered from significant and costly problems that prevented them from running at their promised production capacity, posing a threat to the Company’s pellet plant business, its overall financial performance, and its financial outlook. As a result of this information being withheld from the market, the price of Astec stock was artificially inflated to a high of nearly $70 per share during the Class Period.
To learn more about the Astec Industries, Inc. class action contact jlevi@levikorsinsky.com .
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
